Fellermann K et al. |
Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease. |
2001 |
Transplant. Proc. |
pmid:11377517
|
Salizzoni M et al. |
Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377521
|
Langrehr JM et al. |
Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563. |
2001 |
Transplant. Proc. |
pmid:11377531
|
Migita K and Eguchi K |
FK 506-mediated T-cell apoptosis induction. |
2001 |
Transplant. Proc. |
pmid:11377532
|
Nakache R et al. |
Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization. |
2001 |
Transplant. Proc. |
pmid:11377533
|
Nakatani T et al. |
Effect of tacrolimus on the gene expression of renin and endothelin in the rat kidney. |
2001 |
Transplant. Proc. |
pmid:11377534
|
Schweizer RT and Meisterling LD |
Tolerability of mycophenolate mofetil in organ transplant recipients. |
2001 |
Transplant. Proc. |
pmid:11377540
|
Langrehr JM et al. |
Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial. |
2001 |
Transplant. Proc. |
pmid:11377549
|
Nagashima N et al. |
Immunocompetence assay for net effect of combined immunosuppression. |
2001 |
Transplant. Proc. |
pmid:11377556
|
Chariat MN et al. |
Basiliximab in the therapy of acute rejection after organ transplantation. |
2001 |
Transplant. Proc. |
pmid:11377567
|
Molinaro M et al. |
Pharmacokinetics of tacrolimus during the early phase after heart transplantation. |
2001 |
Transplant. Proc. |
pmid:11377570
|
McCarter JF et al. |
FK 506 protects brain tissue in animal models of stroke. |
2001 |
Transplant. Proc. |
pmid:11377571
|
van Gelder T et al. |
ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications. |
2001 |
Transplant. Proc. |
pmid:11377580
|
Sandborn WJ |
Transcending conventional therapies: the role of biologic and other novel therapies. |
2001 |
Inflamm. Bowel Dis. |
pmid:11380043
|
Teixeira R et al. |
Management of recurrent hepatitis C after liver transplantation. |
2001 |
J. Viral Hepat. |
pmid:11380792
|
Kooman JP et al. |
A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy. |
2001 |
Am. J. Kidney Dis. |
pmid:11382685
|
Barten MJ et al. |
Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro. |
2001 |
J. Immunol. Methods |
pmid:11384672
|
Wakugawa M et al. |
Interferon-gamma-induced RANTES production by human keratinocytes is enhanced by IL-1beta, TNF-alpha, IL-4 and IL-13 and is inhibited by dexamethasone and tacrolimus. |
2001 |
Dermatology (Basel) |
pmid:11385231
|
Goffin E et al. |
Osteoporosis after organ transplantation. |
2001 |
Lancet |
pmid:11386322
|
Boillot O et al. |
Low rejection rates with tacrolimus-based dual and triple regimens following liver transplantation. |
2001 |
Clin Transplant |
pmid:11389705
|
Utsugi R et al. |
Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully mhc-mismatched kidney allografts in miniature swine. |
2001 |
Transplantation |
pmid:11391221
|
Yin DP et al. |
Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. |
2001 |
Transplantation |
pmid:11391223
|
Karasu Z et al. |
Acute tacrolimus overdose and treatment with phenytoin in liver transplant recipients. |
2001 |
J Okla State Med Assoc |
pmid:11392178
|
Maesaki S |
[Molecular mechanize and clinical feature of azole-resistant Candida albicans strains and new strategy of treatment]. |
2001 |
Jpn J Antibiot |
pmid:11392683
|
Tuteja S et al. |
The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients. |
2001 |
Transplantation |
pmid:11397967
|
Otsuka M et al. |
Long-term results of donor-specific blood transfusion with cyclosporine in living related kidney transplantation. |
2001 |
Nephron |
pmid:11399917
|
Bekersky I et al. |
Comparative tacrolimus pharmacokinetics: normal versus mildly hepatically impaired subjects. |
2001 |
J Clin Pharmacol |
pmid:11402631
|
Penson MG et al. |
Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients. |
2001 |
J. Heart Lung Transplant. |
pmid:11404165
|
Allen A et al. |
Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. |
2001 |
Arch Dermatol |
pmid:11405764
|
Diaz-Romero J et al. |
Coexpression of CD4 and CD8alpha on rat T-cells in whole blood: a sensitive marker for monitoring T-cell immunosuppressive drugs. |
2001 |
J. Immunol. Methods |
pmid:11406149
|
Osako M et al. |
Alloimmune response may be involved in neointimal hyperplasia in cryopreserved aortic allografts. |
2001 |
Transplant. Proc. |
pmid:11406250
|
Faivre L et al. |
FK 506 dose in transplantation: from theory to practice. |
2001 |
Transplant. Proc. |
pmid:11406256
|
Chan KL et al. |
Porcine small bowel transplantation with FK506 as a single immunosuppressant. |
2001 |
Transplant. Proc. |
pmid:11406260
|
Charpentier B |
An induction versus no-induction protocol in anticalcineurin-based immunosuppression using very low-dose steroids. |
2001 |
Transplant. Proc. |
pmid:11406262
|
Weir MR |
Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation. |
2001 |
Transplant. Proc. |
pmid:11406264
|
Land W et al. |
Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients. |
2001 |
Transplant. Proc. |
pmid:11406265
|
Sakuma S et al. |
Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids). |
2001 |
Int. Immunopharmacol. |
pmid:11407316
|
Shimoishi K et al. |
FK506 (tacrolimus) increases rat alpha1-acid glycoprotein expression in liver and primary cultured hepatocytes. |
2001 |
Eur. J. Pharmacol. |
pmid:11408029
|
Navarro X et al. |
Effects of FK506 on nerve regeneration and reinnervation after graft or tube repair of long nerve gaps. |
2001 |
Muscle Nerve |
pmid:11410918
|
Hiroi J |
[Pharmacological profile and clinical effect of tacrolimus ointment (Protopic ointment) for atopic dermatitis]. |
2001 |
Nippon Yakurigaku Zasshi |
pmid:11411345
|
Kaibori M et al. |
FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes. |
2001 |
Life Sci. |
pmid:11411802
|
Sun J et al. |
Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration. |
2001 |
Circulation |
pmid:11413088
|
Sing A et al. |
Molecular diagnosis of an Enterocytozoon bieneusi human genotype C infection in a moderately immunosuppressed human immunodeficiency virus seronegative liver-transplant recipient with severe chronic diarrhea. |
2001 |
J. Clin. Microbiol. |
pmid:11414246
|
Kolpak S and Mehler P |
Medical issues in treating renal transplant patients. |
2001 |
Hosp Pract (1995) |
pmid:11419536
|
Chang RK et al. |
Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation. |
2001 |
Pediatr Transplant |
pmid:11422821
|
Hasegawa T et al. |
Oral administration of tacrolimus in the presence of jejunostomy after liver transplantation. |
2001 |
Pediatr Transplant |
pmid:11422824
|
Kanoh S et al. |
FK506 inhibits Cl- secretion in airway epithelium via calcineurin-independent mechanism. |
2001 |
Eur. J. Pharmacol. |
pmid:11426833
|
Mourad M et al. |
Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. |
2001 |
Clin. Chem. |
pmid:11427455
|
Matsuo N et al. |
Tacrolimus inhibits cytokine production and chemical mediator release following antigen stimulation of passively sensitized human lung tissues. |
2001 |
Ann. Allergy Asthma Immunol. |
pmid:11428741
|
Ramm K and Plückthun A |
High enzymatic activity and chaperone function are mechanistically related features of the dimeric E. coli peptidyl-prolyl-isomerase FkpA. |
2001 |
J. Mol. Biol. |
pmid:11428902
|
Lo A et al. |
Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. |
2001 |
Transpl Infect Dis |
pmid:11429034
|
Tanaka K et al. |
FK506 ameliorates the discrimination learning impairment due to preventing the rarefaction of white matter induced by chronic cerebral hypoperfusion in rats. |
2001 |
Brain Res. |
pmid:11430878
|
Boldorini R et al. |
Molecular characterization and sequence analysis of polyomavirus BKV-strain in a renal-allograft recipient. |
2001 |
Hum. Pathol. |
pmid:11431722
|
Dorn GW |
Calcineurin inhibition in hypertrophy: back from the dead! |
2001 |
Circulation |
pmid:11435329
|
Yamataka A et al. |
Bladder transplantation in rats using FK-506. |
2001 |
J. Urol. |
pmid:11435882
|
Singleton RH et al. |
The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury. |
2001 |
J. Neurotrauma |
pmid:11437083
|
Kakegawa T et al. |
[Effect of rapamycin on cytoplasmic accumulation of hetero nuclear ribonucleoprotein C-like unwinding protein 2]. |
2001 |
Jpn J Antibiot |
pmid:11439909
|
Uyeda M et al. |
Pentalenolactone I and hygromycin A, immunosuppressants produced by Streptomyces filipinensis and Streptomyces hygroscopicus. |
2001 |
Biosci. Biotechnol. Biochem. |
pmid:11440152
|
Volosov A et al. |
Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography--tandem mass-spectrometry. |
2001 |
Clin. Biochem. |
pmid:11440728
|
Satoh S et al. |
Chrono and clinical pharmacokinetic study of tacrolimus in continuous intravenous administration. |
2001 |
Int. J. Urol. |
pmid:11442656
|
Neal DA et al. |
Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight. |
2001 |
Liver Transpl. |
pmid:11443583
|
Hurtova M et al. |
Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient. |
2001 |
Liver Transpl. |
pmid:11443588
|
Railson JE et al. |
Heat shock protein-56 is induced by cardiotrophin-1 and mediates its hypertrophic effect. |
2001 |
J. Mol. Cell. Cardiol. |
pmid:11444924
|
Nowak-Wegrzyn AH et al. |
Food allergy after pediatric organ transplantation with tacrolimus immunosuppression. |
2001 |
J. Allergy Clin. Immunol. |
pmid:11447402
|
Harmon JV et al. |
Experimental short-term immunosuppression after bowel transplantation and donor-specific bone marrow infusion. |
2001 |
Arch Surg |
pmid:11448397
|
Taylor DO et al. |
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients. |
2001 |
J. Heart Lung Transplant. |
pmid:11448799
|
Strassburg CP et al. |
Identification of cyclosporine A and tacrolimus glucuronidation in human liver and the gastrointestinal tract by a differentially expressed UDP-glucuronosyltransferase: UGT2B7. |
2001 |
J. Hepatol. |
pmid:11451170
|
Nagler A et al. |
Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment. |
2001 |
J. Hematother. Stem Cell Res. |
pmid:11454316
|
Vennarecci G et al. |
Apoptosis and rejection in rat intestinal transplantation: correlation with FK506 doses and donor specific bone marrow infusions. |
2001 |
Transplantation |
pmid:11455248
|
Papaccio G et al. |
Tacrolimus, but not cyclosporine A, significantly increases expression of ICAM-1 and IFN-gamma in the NOD mouse. |
2001 |
J. Cell. Biochem. Suppl. |
pmid:11455576
|
Koide K et al. |
A synthetic library of cell-permeable molecules. |
2001 |
J. Am. Chem. Soc. |
pmid:11456541
|
Jain A et al. |
Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. |
2001 |
Liver Transpl. |
pmid:11460230
|
Motohashi H et al. |
Effects of tacrolimus and cyclosporin A on peptide transporter PEPT1 in Caco-2 cells. |
2001 |
Pharm. Res. |
pmid:11465431
|
Parvex P et al. |
Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. |
2001 |
Pediatr. Nephrol. |
pmid:11465799
|
Sarwal MM et al. |
Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. |
2001 |
Transplantation |
pmid:11468528
|
Camirand G et al. |
Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice. |
2001 |
Transplantation |
pmid:11468532
|
Squifflet JP et al. |
Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients. |
2001 |
Transplantation |
pmid:11468536
|
Theruvath TP et al. |
Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. |
2001 |
Transplantation |
pmid:11468538
|
Motohashi H et al. |
Expression of peptide transporter following intestinal transplantation in the rat. |
2001 |
J. Surg. Res. |
pmid:11469900
|
Hashimoto Y et al. |
Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis. |
2001 |
Clin. Exp. Immunol. |
pmid:11472421
|
Miki T et al. |
Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease. |
2001 |
Xenotransplantation |
pmid:11472629
|
Ahmed M et al. |
Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells. |
2001 |
Ther Drug Monit |
pmid:11477316
|
Ahsan N et al. |
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. |
2001 |
Transplantation |
pmid:11477347
|
Andries S et al. |
Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. |
2001 |
Transplantation |
pmid:11477351
|
Yamataka A et al. |
Transplantation of newborn esophagus: an experimental study. |
2001 |
J. Pediatr. Surg. |
pmid:11479870
|
Son IJ et al. |
No effect of water deprivation for 48 hours on the pharmacokiinetics of intravenous tacrolimus in rats. |
2000 |
Res. Commun. Mol. Pathol. Pharmacol. |
pmid:11484882
|
Gianni LM and Sulli MM |
Topical tacrolimus in the treatment of atopic dermatitis. |
2001 Jul-Aug |
Ann Pharmacother |
pmid:11485148
|
Zager RA et al. |
Renal cholesterol accumulation: a durable response after acute and subacute renal insults. |
2001 |
Am. J. Pathol. |
pmid:11485932
|
Mück W et al. |
Tacrolimus/cerivastatin interaction study in liver transplant recipients. |
2001 |
Br J Clin Pharmacol |
pmid:11488782
|
James JA et al. |
Tacrolimus is not associated with gingival overgrowth in renal transplant patients. |
2001 |
J. Clin. Periodontol. |
pmid:11493354
|
Meyer D et al. |
Orthotopic liver/small bowel transplantation in rats: a microsurgical model inducing tolerance. |
2001 |
Microsurgery |
pmid:11494384
|
Suzuki Y et al. |
[Mesial temporal lobe epilepsy in a patient with Wilson's disease receiving FK506 (tacrolimus) after liver transplantation]. |
2001 |
No To Hattatsu |
pmid:11494578
|
Zuberbier T et al. |
The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. |
2001 |
J. Allergy Clin. Immunol. |
pmid:11496246
|
Weir M |
Impact of immunosuppressive regimes on posttransplant diabetes mellitus. |
2001 |
Transplant. Proc. |
pmid:11498201
|
Eagle DA et al. |
Gastroparesis following bone marrow transplantation. |
2001 |
Bone Marrow Transplant. |
pmid:11498745
|
Gruessner RW et al. |
Bone marrow augmentation in kidney transplantation: a large animal study. |
2001 |
Transpl. Int. |
pmid:11499905
|
Hwang KK et al. |
FK506 promotes adenosine release from endothelial cells via inhibition of adenosine kinase. |
2001 |
Eur. J. Pharmacol. |
pmid:11502273
|
Takatsuki M et al. |
Weaning of immunosuppression in living donor liver transplant recipients. |
2001 |
Transplantation |
pmid:11502975
|
Lum H et al. |
Protein phosphatase 2B inhibitor potentiates endothelial PKC activity and barrier dysfunction. |
2001 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:11504680
|
Müller WE et al. |
Suppression of allograft rejection in the sponge Suberites domuncula by FK506 and expression of genes encoding FK506-binding proteins in allografts. |
2001 |
J. Exp. Biol. |
pmid:11507104
|